Weekly highlight of top insider buys: Celgene Corp. (CELG, Financial), Valeant Pharmaceuticals Inc. (VRX, Financial), Ecolab Inc. (ECL, Financial), Avnet Inc. (AVT, Financial), and Inergy L.P. (NRGY, Financial).
Celgene Corp. (CELG): Director Ernest Mario Bought 2,000 Shares
Director of Celgene Corp., Ernest Mario, bought 2,000 shares on 12/05/2011 at an average price of $63.58. Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases. Celgene Corp. has a market cap of $28.23 billion; its shares were traded at around $63.58 with a P/E ratio of 20.4 and P/S ratio of 7.8.
On October 27, Celgene Corporation reported Non-GAAP net product sales of $1,218 million for the third quarter of 2011, a 38% increase from the same period in 2010. Non-GAAP net income for the third quarter of 2011 increased 34% to $469 million compared to $350 million in the third quarter of 2010. Based on U.S. GAAP, Celgene reported third quarter 2011 net product sales of $1,219 million and net income of $373 million or $0.81 per diluted share. For the third quarter of 2010, net product sales were $886 million and net income was $281 million or $0.60 per diluted share.
Last week, Director Ernest Mario bought 2,000 shares of CELG stock. CFO Jacqualyn A. Fouse bought 1,000 shares in November. Director Rodman L. Drake bought 500 shares in August. CEO Robert J. Hugin bought 10,000 shares in August.
Valeant Pharmaceuticals International Inc. (VRX): Executive Vice President and CFO Howard Bradley Schiller Bought 54,500 Shares
Executive Vice President and CFO of Valeant Pharmaceuticals International Inc., Howard Bradley Schiller, bought 54,500 shares during the past week at an average price of $47.11. Valeant Pharmaceuticals International Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International Inc. has a market cap of $14.04 billion; its shares were traded at around $47.11 with a P/E ratio of 20.7 and P/S ratio of 11.9.
On November 3, Valeant Pharmaceuticals International Inc. reported results for the third quarter of 2011. Total revenue was $600.6 million in the third quarter of 2011 as compared to $208.3 million in the third quarter of 2010. Product sales were $570.4 million in the third quarter of 2011, as compared to $201.4 million in the year-ago quarter. The company reported net income of $40.9 million for the third quarter of 2011, or $0.13 per diluted share. On a cash EPS basis, income was $212.1 million, or $0.66 per diluted share.
Last week, Executive Vice President and CFO Howard Bradley Schiller bought 11,000 shares of VRX stock. Executive Vice President Administration and CHCO Brian M. Stolz bought 2,400 shares in November. Director Ronald Harold Farmer bought 1,000 shares in September. Executive Vice President, Administration and CHCO Brian M. Stolz, Director Ronald Harold Farmer, and CEO J. Michael Pearson bought shares in August.
Ecolab Inc. (ECL): Director Jerry A. Grundhofer Bought 5,400 Shares
Director of Ecolab Inc., Jerry A. Grundhofer, bought 5,400 shares on 12/05/2011 at an average price of $55.9. Ecolab Inc. is the global leader in cleaning, sanitizing, food safety and infection control products and services. Ecolab Inc. has a market cap of $12.98 billion; its shares were traded at around $55.9 with a P/E ratio of 22.8 and P/S ratio of 2.1. The dividend yield of Ecolab Inc. stocks is 1.3%. Ecolab Inc. had an annual average earnings growth of 10.4% over the past 10 years. GuruFocus rated Ecolab Inc. the business predictability rank of 4-star.
On October 25, Ecolab Inc. reported results for the third quarter of 2011. Ecolab's reported sales rose 11% to a record $1.7 billion in the third quarter of 2011; when measured in fixed currencies, sales rose 6%. Adjusted for currency and acquisitions, sales rose 3%. Reported net income attributable to shareholders declined 11% to $154 million, representing $0.65 per share.
Last week, Director Jerry A. Grundhofer bought 5,400 shares of ECL stock. 10% Owner William H. Gates III bought 754,386 shares in August.
Avnet Inc. (AVT): Director William H. Schumann Bought 5,000 Shares
Director of Avnet Inc., William H. Schumann, bought 5,000 shares on 12/02/2011 at an average price of $30.7. Avnet Inc. is one of the world's largest industrial distributors of electronic components and computer products. Avnet Inc. has a market cap of $4.55 billion; its shares were traded at around $30.7 with a P/E ratio of 7.3 and P/S ratio of 0.2.
On October 27, Avent Inc. reported results for the first fiscal quarter of 2012. Sales for the quarter ended Oct. 1, 2011 increased 3.9% year over year to $6.43 billion; pro forma revenue was up 3.6% year over year and roughly flat in constant currency. Adjusted operating income of $223.1 million, or 3.5% of sales, was essentially flat with last year.
Last week, Director William H. Schumann bought 5,000 shares of AVT stock. Director Eleanor Baum sold 1,000 shares last week. Senior Vice President Philip R. Gallagher, Senior Vice President Harley Feldberg, and Chief Global Logistics Officer Gerard Fay sold shares in November.
Inergy L.P. (NRGY): President Inergy Services William C. Gautreaux Bought 10,000 Shares
President Inergy Services of Inergy L.P., William C. Gautreaux, bought 10,000 shares on 12/07/2011 at an average price of $23.92. Inergy L.P. owns and operates a rapidly growing retail and wholesale propane marketing and distribution business. Inergy L.P. has a market cap of $2.85 billion; its shares were traded at around $23.92 with a P/E ratio of 28.5 and P/S ratio of 1.3. The dividend yield of Inergy L.P. stocks is 11.7%. Inergy L.P. had an annual average earnings growth of 9.5% over the past 10 years.
On November 15, Inergy L.P. reported results of operations for the fiscal fourth quarter and year ended Sept. 30, 2011.Inergy reported Adjusted EBITDA of $372.2 million for the year ended Sept. 30, 2011, an increase of $48.3 million, or approximately 15%, from $323.9 million for the year ended September 30, 2010. Net income loss was $(10.6) million for the year ended Sept. 30, 2011, and $46.4 million in fiscal 2010.
Last week, President Inergy Services William C. Gautreaux bought 10,000 shares of NRGY stock. President/CEO/DIRECTOR John J. Sherman bought 10,000 shares in November. Director Robert D. Taylor bought 800 shares in September.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
Celgene Corp. (CELG): Director Ernest Mario Bought 2,000 Shares
Director of Celgene Corp., Ernest Mario, bought 2,000 shares on 12/05/2011 at an average price of $63.58. Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases. Celgene Corp. has a market cap of $28.23 billion; its shares were traded at around $63.58 with a P/E ratio of 20.4 and P/S ratio of 7.8.
On October 27, Celgene Corporation reported Non-GAAP net product sales of $1,218 million for the third quarter of 2011, a 38% increase from the same period in 2010. Non-GAAP net income for the third quarter of 2011 increased 34% to $469 million compared to $350 million in the third quarter of 2010. Based on U.S. GAAP, Celgene reported third quarter 2011 net product sales of $1,219 million and net income of $373 million or $0.81 per diluted share. For the third quarter of 2010, net product sales were $886 million and net income was $281 million or $0.60 per diluted share.
Last week, Director Ernest Mario bought 2,000 shares of CELG stock. CFO Jacqualyn A. Fouse bought 1,000 shares in November. Director Rodman L. Drake bought 500 shares in August. CEO Robert J. Hugin bought 10,000 shares in August.
Valeant Pharmaceuticals International Inc. (VRX): Executive Vice President and CFO Howard Bradley Schiller Bought 54,500 Shares
Executive Vice President and CFO of Valeant Pharmaceuticals International Inc., Howard Bradley Schiller, bought 54,500 shares during the past week at an average price of $47.11. Valeant Pharmaceuticals International Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharmaceuticals International Inc. has a market cap of $14.04 billion; its shares were traded at around $47.11 with a P/E ratio of 20.7 and P/S ratio of 11.9.
On November 3, Valeant Pharmaceuticals International Inc. reported results for the third quarter of 2011. Total revenue was $600.6 million in the third quarter of 2011 as compared to $208.3 million in the third quarter of 2010. Product sales were $570.4 million in the third quarter of 2011, as compared to $201.4 million in the year-ago quarter. The company reported net income of $40.9 million for the third quarter of 2011, or $0.13 per diluted share. On a cash EPS basis, income was $212.1 million, or $0.66 per diluted share.
Last week, Executive Vice President and CFO Howard Bradley Schiller bought 11,000 shares of VRX stock. Executive Vice President Administration and CHCO Brian M. Stolz bought 2,400 shares in November. Director Ronald Harold Farmer bought 1,000 shares in September. Executive Vice President, Administration and CHCO Brian M. Stolz, Director Ronald Harold Farmer, and CEO J. Michael Pearson bought shares in August.
Ecolab Inc. (ECL): Director Jerry A. Grundhofer Bought 5,400 Shares
Director of Ecolab Inc., Jerry A. Grundhofer, bought 5,400 shares on 12/05/2011 at an average price of $55.9. Ecolab Inc. is the global leader in cleaning, sanitizing, food safety and infection control products and services. Ecolab Inc. has a market cap of $12.98 billion; its shares were traded at around $55.9 with a P/E ratio of 22.8 and P/S ratio of 2.1. The dividend yield of Ecolab Inc. stocks is 1.3%. Ecolab Inc. had an annual average earnings growth of 10.4% over the past 10 years. GuruFocus rated Ecolab Inc. the business predictability rank of 4-star.
On October 25, Ecolab Inc. reported results for the third quarter of 2011. Ecolab's reported sales rose 11% to a record $1.7 billion in the third quarter of 2011; when measured in fixed currencies, sales rose 6%. Adjusted for currency and acquisitions, sales rose 3%. Reported net income attributable to shareholders declined 11% to $154 million, representing $0.65 per share.
Last week, Director Jerry A. Grundhofer bought 5,400 shares of ECL stock. 10% Owner William H. Gates III bought 754,386 shares in August.
Avnet Inc. (AVT): Director William H. Schumann Bought 5,000 Shares
Director of Avnet Inc., William H. Schumann, bought 5,000 shares on 12/02/2011 at an average price of $30.7. Avnet Inc. is one of the world's largest industrial distributors of electronic components and computer products. Avnet Inc. has a market cap of $4.55 billion; its shares were traded at around $30.7 with a P/E ratio of 7.3 and P/S ratio of 0.2.
On October 27, Avent Inc. reported results for the first fiscal quarter of 2012. Sales for the quarter ended Oct. 1, 2011 increased 3.9% year over year to $6.43 billion; pro forma revenue was up 3.6% year over year and roughly flat in constant currency. Adjusted operating income of $223.1 million, or 3.5% of sales, was essentially flat with last year.
Last week, Director William H. Schumann bought 5,000 shares of AVT stock. Director Eleanor Baum sold 1,000 shares last week. Senior Vice President Philip R. Gallagher, Senior Vice President Harley Feldberg, and Chief Global Logistics Officer Gerard Fay sold shares in November.
Inergy L.P. (NRGY): President Inergy Services William C. Gautreaux Bought 10,000 Shares
President Inergy Services of Inergy L.P., William C. Gautreaux, bought 10,000 shares on 12/07/2011 at an average price of $23.92. Inergy L.P. owns and operates a rapidly growing retail and wholesale propane marketing and distribution business. Inergy L.P. has a market cap of $2.85 billion; its shares were traded at around $23.92 with a P/E ratio of 28.5 and P/S ratio of 1.3. The dividend yield of Inergy L.P. stocks is 11.7%. Inergy L.P. had an annual average earnings growth of 9.5% over the past 10 years.
On November 15, Inergy L.P. reported results of operations for the fiscal fourth quarter and year ended Sept. 30, 2011.Inergy reported Adjusted EBITDA of $372.2 million for the year ended Sept. 30, 2011, an increase of $48.3 million, or approximately 15%, from $323.9 million for the year ended September 30, 2010. Net income loss was $(10.6) million for the year ended Sept. 30, 2011, and $46.4 million in fiscal 2010.
Last week, President Inergy Services William C. Gautreaux bought 10,000 shares of NRGY stock. President/CEO/DIRECTOR John J. Sherman bought 10,000 shares in November. Director Robert D. Taylor bought 800 shares in September.
For the complete list of stocks that bought by their company executives, go to: Insider Buys.
